(RDIV) Invesco S&P Ultra Dividend - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46138G6567 • Mid-Cap Value

RDIV: Stocks, US, Dividend-paying, Large-cap

The Invesco S&P Ultra Dividend Revenue ETF (NYSE Arca: RDIV) is designed to provide exposure to high-quality, dividend-paying stocks within the S&P 900 Index. The fund typically allocates at least 90% of its total assets to securities that make up its underlying index, which is crafted to track the performance of revenue-generating companies with a history of consistent dividend payments. This focus on dividend-paying stocks makes it a potential choice for income-seeking investors. The ETF is classified as non-diversified, meaning it can invest a significant portion of its assets in a smaller number of securities, which may increase risk but also allows for concentrated exposure to its investment strategy.

For more information, visit the Invesco website at www.invesco.com/us.

As of the latest data, the ETF manages approximately $814.06M USD in assets, reflecting its appeal to investors looking for a mid-cap value strategy with a focus on dividend-paying stocks. The funds structure allows it to tap into the S&P 900, which includes a broader range of companies compared to the more narrowly focused S&P 500, potentially offering diversification benefits and access to mid-sized firms with strong revenue and dividend profiles.

Looking ahead, the ETFs future outlook hinges on the continued strength of mid-cap value stocks and the sustainability of dividend payments from its constituents. As interest rates rise and inflation concerns persist, dividend-focused strategies may face headwinds, but they could also benefit if investors seek yield in a lower-return environment. The funds ability to maintain its dividend yield while navigating market volatility will be critical to its success. Additionally, the ETFs non-diversified nature means it may be more sensitive to sector-specific risks, particularly in industries with high dividend payouts. However, its alignment with the S&P 900 provides a level of stability, as the index is designed to include only revenue-producing companies, potentially mitigating some of the risks associated with more speculative investments.

Additional Sources for RDIV ETF

RDIV ETF Overview

Market Cap in USD 740m
Category Mid-Cap Value
TER 0.39%
IPO / Inception 2013-09-30

RDIV ETF Ratings

Growth Rating 77.0
Fundamental -
Dividend Rating 67.9
Rel. Strength -2.2
Analysts -
Fair Price Momentum 45.40 USD
Fair Price DCF -

RDIV Dividends

Dividend Yield 12m 4.20%
Yield on Cost 5y 9.37%
Annual Growth 5y 3.34%
Payout Consistency 96.1%

RDIV Growth Ratios

Growth Correlation 3m -70%
Growth Correlation 12m 57.2%
Growth Correlation 5y 87%
CAGR 5y 16.80%
CAGR/Max DD 5y 0.68
Sharpe Ratio 12m 1.02
Alpha -0.91
Beta 0.631
Volatility 28.74%
Current Volume 29.7k
Average Volume 20d 57.2k
What is the price of RDIV stocks?
As of April 28, 2025, the stock is trading at USD 45.58 with a total of 29,685 shares traded.
Over the past week, the price has changed by +4.16%, over one month by -6.58%, over three months by -8.00% and over the past year by +6.93%.
Is Invesco S&P Ultra Dividend a good stock to buy?
Yes. Based on ValueRay Analyses, Invesco S&P Ultra Dividend (NYSE ARCA:RDIV) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.02 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RDIV as of April 2025 is 45.40. This means that RDIV is currently overvalued and has a potential downside of -0.39%.
Is RDIV a buy, sell or hold?
Invesco S&P Ultra Dividend has no consensus analysts rating.
What are the forecast for RDIV stock price target?
According to ValueRays Forecast Model, RDIV Invesco S&P Ultra Dividend will be worth about 50.6 in April 2026. The stock is currently trading at 45.58. This means that the stock has a potential upside of +10.9%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 50.6 10.9%